Combination comprising methotrexate and an antifolate compound
AU2011202657A1
Quinazoline derivatives as metabolically inert antifolate compounds
US2011237609A1
Antifolate compositions
AU2010315152A1
Enzyme inhibiting compounds
EP2451788A1
Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl]-benzoylamino} -4-methylen -penta nedioic acid
MX2010010999A
Crystalline salt forms of antifolate compounds and methods of manufacturing thereof.
AU2008248382A1
Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders
EP2142185A2
Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
BRPI0808647A2
Method to treat central sensitivity syndrome, method to reduce, eliminate or prevent pain associated with fibromyalgy, useful kit for treatment of central sensitivity syndrome.
AU2008213147A1
New compounds, methods for their preparation and use thereof
NZ578549A
New classical antifolates
US2006111272A1
Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation
